Naver Corp

SEONGNAM, South Korea, March 30, 2026 /PRNewswire/ -- NAVER D2SF, the corporate venture capital arm of NAVER, has made a follow-on investment in Nuvilab, an AI-powered nutrition analytics healthcare startup. Following its seed investment shortly after the company's founding in 2021, NAVER D2SF has participated again in Nuvilab's Series A bridge round, recognizing its strong growth potential in the North American healthcare market.

Nuvilab has developed a nutrition management solution that analyzes food type, intake, and nutritional content in real time using image-based scanning. By installing scanners in everyday environments such as daycare centers, hospitals, and schools, the company enables seamless and passive data collection. This approach has led to a 95% retention rate, significantly exceeding the healthcare industry average. Powered by a multimodal AI model trained on over 100 million food data points, Nuvilab's technology delivers 98% accuracy within 0.3 seconds.

After establishing strong product validation in Korea's B2B and B2G markets, Nuvilab is now accelerating its expansion into the North American healthcare sector. The company is refining its solution to enhance patient care productivity in hospitals while rapidly growing its customer base. As of the end of 2025, Nuvilab has secured over 1,000 global clients and 100,000 active users. It has also signed an exclusive partnership with one of the world's largest catering groups to supply its solution to hospitals in the United States.

Notably, Nuvilab is demonstrating tangible value in hospital food safety management. By automating the verification process that matches patient meal tickets with actual meals served, its AI solution has reduced errors by 49% and shortened food preparation time by 23% compared to manual processes, based on PoC results. Building on this traction, the company plans to expand into broader healthcare applications, including dietary intake analytics and integrations with insurers and pharmaceutical companies.

"Despite being one of the most critical areas in healthcare, dietary habits have remained largely unstructured and underutilized," said Logan Kim, CEO of Nuvilab. "Nuvilab aims to structure dietary data through AI and grow into a global category-defining company that fundamentally reshapes healthcare."

"Building on its proven technology and business expertise in Korea, Nuvilab has quickly achieved product-market fit in North America," said Sanghwan Yang, Head of NAVER D2SF. "We will continue to support startups that challenge global markets and demonstrate strong growth potential."

About NAVER D2SF

NAVER D2SF is NAVER's in-house corporate venture arm, supporting sustainable growth by collaborating with startups. Founded in 1999, NAVER has maintained its position as Korea's leading search engine for over 20 years and operates across commerce, content, fintech, and cloud services. Under the technological vision of D2 (For Developers, By Developers), NAVER is actively developing new technologies and global partnerships to grow as a leading tech company.

To learn more, visit https://d2sf.naver.com 

View original content:https://www.prnewswire.com/news-releases/naver-d2sf-makes-follow-on-investment-in-nuvilab-ai-nutrition-analytics-startup-302728401.html

SOURCE NAVER

SEOUL, South Korea, March 30, 2026 /PRNewswire/ -- NAVER D2SF, the corporate venture capital arm of NAVER, has made a follow-on investment in Soundable Health, a health tech startup leveraging AI-powered acoustic analysis to enable clinical-grade diagnostics through everyday devices. Having participated in Soundable Health's seed round in 2019, NAVER D2SF joined this Pre-Series A round, citing the company's demonstrated product-market fit (PMF) and strong growth trajectory in the U.S. healthcare market.

Soundable Health has developed proprietary AI models that analyze acoustic signals generated by the human body to monitor health conditions. Its flagship product, proudP, is a clinical-grade solution that analyzes urine flow sounds to assess and track urinary symptoms associated with conditions such as benign prostatic hyperplasia (BPH) and overactive bladder (OAB). Built on a dataset of over 500,000 real-world home tests, the smartphone-based solution achieves 97% accuracy without requiring specialized hardware.

As an FDA Class II medical device, proudP delivers clinical-grade measurements while meeting stringent standards for quality and data privacy. By removing the need for clinic-based equipment, the solution significantly improves accessibility, enabling patients to perform uroflowmetry tests conveniently at home.

To date, proudP has been adopted by over 130 urology clinics and 50,000 patients across the United States, with continued growth in both direct-to-consumer usage and long-term engagement. In 2026, the company expects accelerated adoption as the service becomes eligible for insurance reimbursement, including Medicare. Soundable Health is also expanding B2B partnerships with global pharmaceutical, medical device, and consumer electronics companies, while extending its platform to adjacent areas such as respiratory monitoring through cough analysis.

The Soundable Health team brings deep expertise across AI, data science, and healthcare. From the start, the company has validated its technology through rigorous clinical and commercial execution in real-world healthcare settings.

"As populations age globally, there is a growing need for simple, continuous, and accessible health monitoring. We see acoustic AI as a foundational technology for the aging space—enabling earlier detection, better chronic care management, and more independent living." said Catherine Song, Ph.D., Co-founder and CEO of Soundable Health. "With expanding insurance coverage and B2B partnerships in 2026, we are positioned to scale this capability across urology, respiratory health, and beyond."

"Successful global expansion requires not only strong technology, but also the ability to build products that truly meet the needs of customers and the market," said Sanghwan Yang, Head of NAVER D2SF. "Soundable Health has demonstrated this through its strong execution and persistence, and we expect continued growth in the North American healthcare market."

Website: https://soundable.health

About NAVER D2SF

NAVER D2SF is NAVER's in-house corporate venture arm, supporting sustainable growth by collaborating with startups. Founded in 1999, NAVER has maintained its position as Korea's leading search engine for over 20 years and operates across commerce, content, fintech, and cloud services. Under the technological vision of D2 (For Developers, By Developers), NAVER is actively developing new technologies and global partnerships to grow as a leading tech company.

To learn more, visit https://d2sf.naver.com

View original content:https://www.prnewswire.com/news-releases/naver-d2sf-makes-follow-on-investment-in-soundable-health-an-ai-driven-health-tech-startup-scaling-in-the-us-market-302728398.html

SOURCE NAVER